Results 251 to 260 of about 4,150,951 (316)

Practical Guidance on Clinical Management of Belantamab Mafodotin‐Associated Ocular Events

American Journal of Hematology, EarlyView.
ABSTRACT Importance Belantamab mafodotin (belamaf)‐containing regimens are effective treatment options for patients with relapsed and/or refractory multiple myeloma. Ocular events are a common adverse effect of belamaf treatment, which can be managed by physicians, following appropriate training, to minimize their impact on the patient.
Evangelos Terpos, Suzanne Trudel, María‐Victoria Mateos, Nicolás Alejandre, Kathryn Colby, Meletios A. Dimopoulos, Simona Degli Esposti, Asim V. Farooq, Maria Gavriatopoulou, Francesca Gay, Vania Hungria, K. Martin Kortüm, Xavier Leleu, Sagar Lonial, Hang Quach, Lugui Qiu, Karthik Ramasamy, Kazuhito Suzuki, Katja C. Weisel, Paul Richardson   +19 more
wiley   +1 more source

In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper

Allergy. European Journal of Allergy and Clinical Immunology, 2016
C. Mayorga, Gülfem Çelik, P. Rouzaire, Paul Whitaker, P. Bonadonna, J. Rodrigues-Cernadas, A. Vultaggio, K. Brockow, J. C. Caubet, Joanna Makowska, A. Nakonechna, A. Romano, M. Montañez, J. Laguna, G. Zanoni, J. Guéant, H. Elberink, Javier Fernández, S. Viel, Pascal Demoly, Marta E. Torres   +20 more
semanticscholar   +1 more source

Association Of Food And Drug Allergy With Antituberculosis Drug Related Hepatitis Or Skin Reactions: A Case Control Study

, 2014
Dinesh LB Dassanayake, BKM Asanga Upul, Kiruna Wickramasekara, SK Ileperuma, Anoma Siribaddana, KA Wijewardena   +5 more
openalex   +2 more sources

Evaluation of Morbidity and Mortality from Drug Allergies in Patient with Acute Myeloid Leukemia [PDF]

, 2018
Maria Paula Henao, Faoud T. Ishmael
openalex   +1 more source

What can we learn in drug allergy management from World Health Organization's international classifications?

Allergy. European Journal of Allergy and Clinical Immunology, 2018
L. Tanno, M. J. Torres, Mariana Castells, Pascal Demoly   +3 more
semanticscholar   +1 more source

An urgent need for capacity building towards establishment of drug allergy management systems in the Indian sub-continent. [PDF]

Lancet Reg Health Southeast Asia
Krishna MT, Liyanage G, Shrestha R, Jordan RE, Christopher DJ.   +4 more
europepmc   +1 more source

L-Asparaginase-Induced Allergy in Mice: Effects of Concomitant Drugs and Anti-IgE Antibody

, 2016
Ai Nogami-Hara, Kazuki Hara, Yasuhiro Kawakami, Akira Shimada, Mitsunobu Mio   +4 more
openalex   +1 more source

Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience

American Journal of Hematology, EarlyView.
ABSTRACT Breakthrough hemolysis (BTH) is defined as a hemolytic exacerbation in a patient with paroxysmal nocturnal hemoglobinuria (PNH) treated with complement inhibitors (CIs). In the current era of several terminal and proximal inhibitors, there are no guidelines for defining BTH and its severity, and clinical management is not standardized.
Bruno Fattizzo, Giacinto Luca Pedone, Elisabetta Metafuni, Eloise Beggiato, Valentina Giai, Esther Natalie Oliva, Antony Ricchiuti, Marta Bortolotti, Simona Raso, Daniela Carlino, Mara Memoli, Sofia Vecchi, Jennifer Vidler, Sukanya Gogoi, Shreya Goel, Anna Corby, Roochi Trikha, Sneha Balakrishnan, Francesco Passamonti, Anna Paola Iori, Simona Sica, Shreyans Gandhi, Wilma Barcellini, Austin Kulasekararaj   +23 more
wiley   +1 more source

Residents and interns in the 3 university hospitals: their knowledge of and attitudes to drug allergy. [PDF]

Asia Pac Allergy, 2020
Gökmirza Özdemir P, Kızılca Ö, Aylanç H, Çelik V, Beken B, Akbulut SD, Yazıcıoğlu M, Süt N.   +7 more
europepmc   +1 more source

Acute drug allergy after getting medical treatment from a primary care unit: Comment and discussion

, 2016
Beuy Joob, Viroj Wiwanitkit
openalex   +1 more source